Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria.
We investigated the seroprevalence of human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) infection among 258 clergymen-in-training (age range 18-39 years) who represented a donor population that fulfilled the criteria for safe blood transfusion. In all, 15.1% of the men were positive for HBsAg, 4.3% were positive for anti-HCV and 2.7% were HIV-positive; 22.1% were infected with at least one of these viruses. Co-infection with HIV and HBV was found in 0.4% of the subjects, HBV and HCV in 0.4%, and HIV and HCV in 0%. This underscores the importance of routine screening of blood before transfusion, regardless of the donor background.
Egah
D Z
DZ
Department of Medical Microbiology, Jos University Teaching Hospital, Jos, Nigeria. danegah@yahoo.com
Banwat
E B
EB
Audu
E S
ES
Iya
D
D
Mandong
B M
BM
Anele
A A
AA
Gomwalk
N E
NE
D000293:Adolescent; D000328:Adult; D001782:Blood Donors / Q000706:statistics & numerical data*; D002977:Clergy / Q000706:statistics & numerical data*; D015897:Comorbidity; D015483:HIV Antibodies / Q000097:blood*; D015658:HIV Infections / Q000097:blood / Q000453:epidemiology / Q000276:immunology; D015528:HIV Seroprevalence; D006509:Hepatitis B / Q000097:blood / Q000453:epidemiology / Q000276:immunology; D006510:Hepatitis B Antibodies / Q000097:blood*; D006514:Hepatitis B Surface Antigens / Q000276:immunology*; D006526:Hepatitis C / Q000097:blood / Q000453:epidemiology / Q000276:immunology; D018937:Hepatitis C Antibodies / Q000097:blood*; D006785:Hospitals, University; D006801:Humans; D008297:Male; D008403:Mass Screening; D009549:Nigeria / Q000453:epidemiology; D011159:Population Surveillance; D011446:Prospective Studies; D012307:Risk Factors; D017751:Safety Management; D016036:Seroepidemiologic Studies
D015483:HIV Antibodies; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D018937:Hepatitis C Antibodies